AYAL Capital Advisors Ltd Sells 115,635 Shares of Orthofix Medical Inc. (NASDAQ:OFIX)

AYAL Capital Advisors Ltd lessened its position in Orthofix Medical Inc. (NASDAQ:OFIX) by 17.6% in the fourth quarter, according to its most recent disclosure with the SEC. The firm owned 539,871 shares of the medical device company’s stock after selling 115,635 shares during the period. Orthofix Medical makes up about 2.5% of AYAL Capital Advisors Ltd’s holdings, making the stock its 2nd largest position. AYAL Capital Advisors Ltd’s holdings in Orthofix Medical were worth $9,426,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also recently modified their holdings of the company. JPMorgan Chase & Co. lifted its position in Orthofix Medical by 244.1% in the 4th quarter. JPMorgan Chase & Co. now owns 290,351 shares of the medical device company’s stock valued at $5,070,000 after acquiring an additional 205,972 shares in the last quarter. Dimensional Fund Advisors LP lifted its holdings in shares of Orthofix Medical by 31.8% in the fourth quarter. Dimensional Fund Advisors LP now owns 659,475 shares of the medical device company’s stock valued at $11,515,000 after purchasing an additional 159,177 shares in the last quarter. Emerald Mutual Fund Advisers Trust boosted its position in shares of Orthofix Medical by 35.4% during the fourth quarter. Emerald Mutual Fund Advisers Trust now owns 503,802 shares of the medical device company’s stock valued at $8,796,000 after buying an additional 131,653 shares during the last quarter. Emerald Advisers LLC grew its holdings in Orthofix Medical by 12.2% during the fourth quarter. Emerald Advisers LLC now owns 822,377 shares of the medical device company’s stock worth $14,359,000 after buying an additional 89,717 shares in the last quarter. Finally, Arrowstreet Capital Limited Partnership purchased a new stake in Orthofix Medical in the 4th quarter valued at $1,286,000. Institutional investors own 89.76% of the company’s stock.

Orthofix Medical Trading Up 1.8 %

NASDAQ OFIX opened at $13.79 on Friday. The business’s fifty day moving average is $15.34 and its 200-day moving average is $17.03. The company has a debt-to-equity ratio of 0.25, a current ratio of 2.39 and a quick ratio of 1.11. The stock has a market capitalization of $538.11 million, a price-to-earnings ratio of -4.41 and a beta of 0.99. Orthofix Medical Inc. has a one year low of $12.08 and a one year high of $20.73.

Wall Street Analyst Weigh In

A number of equities analysts have issued reports on OFIX shares. Canaccord Genuity Group reaffirmed a “buy” rating and set a $24.00 price objective on shares of Orthofix Medical in a report on Wednesday, February 26th. Roth Mkm restated a “buy” rating and set a $22.00 price target on shares of Orthofix Medical in a report on Wednesday, February 26th. Finally, StockNews.com raised shares of Orthofix Medical from a “hold” rating to a “buy” rating in a research report on Tuesday, February 25th. Five analysts have rated the stock with a buy rating, Based on data from MarketBeat.com, Orthofix Medical has a consensus rating of “Buy” and an average price target of $23.33.

Insider Buying and Selling

In other Orthofix Medical news, insider Lucas Vitale sold 4,287 shares of the firm’s stock in a transaction on Tuesday, March 18th. The stock was sold at an average price of $16.60, for a total value of $71,164.20. Following the completion of the sale, the insider now directly owns 135,317 shares of the company’s stock, valued at $2,246,262.20. This trade represents a 3.07 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through this link. Also, insider Jorge Andres Cedron sold 3,816 shares of the company’s stock in a transaction on Wednesday, April 16th. The shares were sold at an average price of $13.31, for a total value of $50,790.96. Following the transaction, the insider now directly owns 42,500 shares in the company, valued at $565,675. This represents a 8.24 % decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 9,242 shares of company stock worth $141,710. Insiders own 2.60% of the company’s stock.

About Orthofix Medical

Orthofix Medical Inc operates as a spine and orthopedics company in the United States, Italy, Germany, the United Kingdom, France, Brazil, and internationally. It operates through two segments, Global Spine and Global Orthopedics. The Global Spine segment manufactures and distributes bone growth stimulator devices for enhance of bone fusion, including adjunctive and noninvasive treatment of cervical and lumbar spine, as well as a therapeutic treatment for non-spine; designs, develops, and markets a portfolio of motion preservation and fixation implant products, which are used in surgical procedures of the spine; and offers biological products, such as fiber-based and particulate demineralized bone matrices, cellular bone allografts, collagen ceramic matrices, and synthetic bone void fillers, and tissue forms, which allow physicians to treat various spinal and orthopedic conditions.